Its been long enough since the phase 2 study, and I believe they should be able to issue like an interim result? Just to keep investor interested and updated
not a pharma guy tho.
- Forums
- ASX - By Stock
- IMM
- Merck US$1.85b takeover of clinical autoimmune biotech company
Merck US$1.85b takeover of clinical autoimmune biotech company, page-33
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
32.0¢ |
Change
0.020(6.67%) |
Mkt cap ! $464.8M |
Open | High | Low | Value | Volume |
30.5¢ | 32.3¢ | 30.0¢ | $1.040M | 3.328M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 42705 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.315 |
4 | 120476 | 0.310 |
4 | 137420 | 0.305 |
2 | 39246 | 0.295 |
4 | 20750 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 42705 | 2 |
0.325 | 27420 | 2 |
0.330 | 186564 | 5 |
0.335 | 33333 | 1 |
0.340 | 45281 | 5 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
NEWS
Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
NEWS
Is oil undervalued?
IMM (ASX) Chart |